Edwards’ Ecliptis Wins FDA Clearance, Challenges AtriCure in Surgical LAA Market
Edwards got FDA OK for heart clip; it enters a market led by AtriCure, adding competition but not changing the outlook much.
NOTRELOAD AI
Super Micro Offices Raided in Taiwan as Chip Smuggling Probe Widens
Taiwan raided Super Micro offices on June 29, 2026, as part of an expanding investigation into alleged smuggling of Nvidia AI chips to China.
Carlisle Makes Multiple Unsolicited Bids for Owens Corning in Potential $10 Billion Deal
The move could create a major building materials powerhouse amid sector consolidation.
QuidelOrtho Eyes $1.5B Sale of COVID-Era Rapid Testing Business
The unit, once a pandemic star, attracts strong private equity interest.
Palisade Bio Stock Surges on Positive FDA Clearance for Next-Gen IBD Therapy
The FDA has cleared Palisade Bio’s investigational new drug application for PALI-2108. The company will now start its Phase 2 ASCENTRA-UC trial in H2 2026.
Forager Raises Take-Private Offer for Repay Holdings to $5.25 Per Share
Repay shares jumped 22% after Forager raised its buyout offer to $5.25 cash, but the deal is still not final.